FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies
How real human experiences can power a healthier future
UK trials digital ‘health passport’ to help borders reopen
Kite cues up first EMA okay for mantle cell lymphoma CAR-T
Novartis’ big bet on inclisiran nears fruition, as CHMP backs drug

Tunnah

Available on-demand: COPD, connecting real world needs to patient centric solutions

COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and

Available on-demand: COPD, connecting real world needs to patient centric solutions

https://pharmaphorum.com/debates-insight-patients/live-webinar-debate-feb-4th-copd-connecting-real-world-needs-to-patient-centric-solutions-price-is-right-uk-niche-market-access-2/

Available on-demand: The Price is Right? – Delivering UK access for niche patient populations

With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what

Available on-demand: The Price is Right? – Delivering UK access for niche patient populations

https://pharmaphorum.com/debates-insight-market-access/live-webinar-the-price-is-right-uk-niche-market-access/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Search

Advanced Search

Trending

Tunnah

Available on-demand: COPD, connecting real world needs to patient centric solutions

Available on-demand: The Price is Right? – Delivering UK access for niche patient populations